galactosamine has been researched along with dinoprostone in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirota, K; Hishinuma, I; Katayama, K; Miyamoto, K; Nagakawa, J; Yamanaka, T; Yamatsu, I | 1 |
| Hildebrandt, J; Lam, C; Liehl, E; Proctor, RA; Rosenwirth, B; Schütze, E; Stütz, P | 1 |
| Busse, R; Decker, K; Gyufko, K; Henninger, H; Tran-Thi, TA | 1 |
| Chang, TM; Zhou, MX | 1 |
| Chang, TM; Dixit, V | 1 |
| Han, K; Hashimoto, N; Kato, N; Kawase, T; Komatsu, Y; Matsumura, M; Niwa, Y; Shiina, S; Shiratori, Y; Tada, M | 1 |
| Fischer, W; Schudt, C; Wendel, A | 1 |
| Kawasaki, H; Okano, J; Shiota, G | 1 |
| Alvarez-Soria, MA; Calvo, E; Díez-Ortego, I; Egido, J; Herrero-Beaumont, G; Largo, R; Sánchez-Pernaute, O | 1 |
| Bae, JH; Han, SB; Jang, BC; Park, GY; Park, JG; Park, JW; Shin, DH; Suh, SI; Sung, SH | 1 |
| Fu, N; Liu, Y; Lu, X; Pan, Q; Wu, S; Zheng, J; Zhu, P | 1 |
| Cho, JY; Kim, D; Yi, YS | 1 |
| Choi, I; Doh, KO; Jeong, JH; Kim, BK; Kim, HS; Kim, JO; Lee, DM; Moon, IJ; Nguyen, TT; Park, JB; Park, PH; Pathak, S; Regmi, S; Seo, Y; Sung, JH; Thanh, TP; Yong, CS; Yook, S | 1 |
13 other study(ies) available for galactosamine and dinoprostone
| Article | Year |
|---|---|
Protective effects of E3330, a novel quinone derivative, on galactosamine/tumor necrosis factor-alpha-induced hepatitis in mice.
Topics: Animals; Ascitic Fluid; Benzoquinones; Chemical and Drug Induced Liver Injury; Dinoprostone; Galactosamine; In Vitro Techniques; Leukotriene B4; Male; Mice; Mice, Inbred C3H; Propionates; Rats; Thromboxane B2; Tumor Necrosis Factor-alpha | 1992 |
Immunostimulatory, but not antiendotoxin, activity of lipid X is due to small amounts of contaminating N,O-acylated disaccharide-1-phosphate: in vitro and in vivo reevaluation of the biological activity of synthetic lipid X.
Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Dinoprostone; Disaccharides; Dose-Response Relationship, Drug; Endotoxins; Female; Galactosamine; Glycolipids; Humans; In Vitro Techniques; Interleukin-1; Limulus Test; Macrophages; Mice; Mice, Inbred Strains; Monocytes; Neutrophils; Pyrogens; Rabbits; Shwartzman Phenomenon; Sugar Phosphates; Superoxides; Tumor Necrosis Factor-alpha | 1991 |
Studies on synthesis and degradation of eicosanoids by rat hepatocytes in primary culture.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cells, Cultured; Dinoprost; Dinoprostone; Female; Galactosamine; Leukotriene B4; Liver; Prostaglandin D2; Prostaglandins; Prostaglandins D; Prostaglandins E; Prostaglandins F; Rats; Rats, Inbred Strains; Thromboxane B2 | 1987 |
Effects of polylactic acid microcapsules containing prostaglandin E2 on the survival rates of grade II coma galactosamine induced fulminant hepatic failure rats.
Topics: Animals; Capsules; Delayed-Action Preparations; Dinoprostone; Galactosamine; Hepatic Encephalopathy; Lactates; Lactic Acid; Male; Polyesters; Polymers; Prostaglandins E; Rats; Rats, Inbred Strains | 1987 |
Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Dinoprostone; Galactosamine; Hepatic Encephalopathy; Liver; Male; Microscopy, Electron; Prostaglandins E; Rats; Rats, Inbred Strains | 1987 |
Role of polymorphonuclear leukocytes in galactosamine hepatitis: mechanism of adherence to hepatic endothelial cells.
Topics: Alprostadil; Animals; Cell Adhesion; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chi-Square Distribution; Dinoprostone; Endothelium; Galactosamine; Intercellular Adhesion Molecule-1; Lipopolysaccharides; Liver; Male; Neutrophil Activation; Neutrophils; Rats; Superoxide Dismutase; Superoxides; Tumor Necrosis Factor-alpha | 1994 |
Protection by phosphodiesterase inhibitors against endotoxin-induced liver injury in galactosamine-sensitized mice.
Topics: Animals; Cells, Cultured; Colforsin; Cyclic AMP; Dinoprostone; Galactosamine; Hepatitis; Lipopolysaccharides; Liver; Macrophages; Male; Mice; Phosphodiesterase Inhibitors; Pyridazines; Pyrrolidinones; Rolipram; Shock, Septic; Tumor Necrosis Factor-alpha | 1993 |
Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice.
Topics: Acute Disease; Alanine Transaminase; Animals; Antibodies; Chemical and Drug Induced Liver Injury; Dinoprostone; Dose-Response Relationship, Drug; Galactosamine; Hepatocyte Growth Factor; Humans; Injections, Intravenous; Liver; Mice; Mice, Inbred Strains; Mice, Transgenic; Portal Vein; Proliferating Cell Nuclear Antigen; Staining and Labeling; Survival Analysis | 1997 |
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes.
Topics: Acetylglucosamine; Blotting, Western; Cartilage, Articular; Cells, Cultured; Chondrocytes; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Electrophoretic Mobility Shift Assay; Fluorescent Antibody Technique; Galactosamine; Gene Expression Regulation, Enzymologic; Glucosamine; Humans; Interleukin-1; Isoenzymes; Membrane Proteins; NF-kappa B; Osteoarthritis, Knee; Prostaglandin-Endoperoxide Synthases | 2003 |
Glucosamine hydrochloride specifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner.
Topics: Cell Line, Tumor; Chlorides; Cyclooxygenase 2; Dinoprostone; Epithelium; Galactosamine; Glucosamine; Glycosylation; Humans; Inflammation; Interleukin-1beta; Lung; Models, Biological; Osteoarthritis; Proteasome Endopeptidase Complex | 2007 |
Protective effect of chloral hydrate against lipopolysaccharide/D-galactosamine-induced acute lethal liver injury and zymosan-induced peritonitis in mice.
Topics: Animals; Anti-Inflammatory Agents; Cells, Cultured; Chemical and Drug Induced Liver Injury; Chloral Hydrate; Cyclooxygenase 2; Cytokines; Cytoprotection; Dinoprostone; Galactosamine; Inflammation Mediators; Lipopolysaccharides; Mice; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide Synthase Type II; Peritonitis; Zymosan | 2010 |
Cerbera manghas methanol extract exerts anti-inflammatory activity by targeting c-Jun N-terminal kinase in the AP-1 pathway.
Topics: Animals; Anti-Inflammatory Agents; Apocynaceae; Chemical and Drug Induced Liver Injury; Cytokines; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Galactosamine; HEK293 Cells; Humans; Inflammation Mediators; JNK Mitogen-Activated Protein Kinases; Kaempferols; Lipopolysaccharides; Macrophage Activation; Macrophages; Male; Methanol; Mice; Mice, Inbred C57BL; Peritonitis; Phosphorylation; Phytotherapy; Plant Extracts; Plants, Medicinal; RAW 264.7 Cells; Signal Transduction; Solvents; Time Factors; Transcription Factor AP-1 | 2016 |
Intraportally delivered stem cell spheroids localize in the liver and protect hepatocytes against GalN/LPS-induced fulminant hepatic toxicity.
Topics: Animals; Cell Culture Techniques; Cell Survival; Dinoprostone; Disease Models, Animal; Galactosamine; Heme Oxygenase-1; Interleukin-10; Lipopolysaccharides; Liver; Liver Failure, Acute; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Nude; Oxidative Stress; Reactive Oxygen Species; Superoxide Dismutase | 2019 |